FeedsFarm.com > FDA Expands Use of Herceptin for Early Stage Breast Cancer After Primary Therapy

Source:

Food and Drug Administration

Language:

English

Domain:

www.fda.gov

More feeds from fda.gov:

• Food and Drug Administration

Search fda.gov:

FDA Expands Use of Herceptin for Early Stage Breast Cancer After Primary Therapy

17th Nov 2006, 03:14 GMT

The new indication is for Herceptin, in combination with other cancer drugs, for the treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy).

Latest news from Food and Drug Administration:

• FDA's Dr. Boris Lushniak Receives AMA Award
• HHS and FDA Announce New Tools to Help Consumers Use the Nutrition Facts Label
• FDA Invites Input on Electronic Submission of Regulatory Information